Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
FTV 
Fortive Corp (FTV)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
10/15/2025: FTV (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
20 Analysts rated it
Well-followed company, solid analyst reports, reliable data for confident investing.
1 Year Target Price $56.81
1 Year Target Price $56.81
| 6 | Strong Buy |
| 5 | Buy |
| 9 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -11.04% | Avg. Invested days 33 | Today’s Advisory WEAK BUY |
Upturn Star Rating | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 10/15/2025 |
Key Highlights
Company Size Large-Cap Stock | Market Capitalization 16.47B USD | Price to earnings Ratio 21.93 | 1Y Target Price 56.81 |
Price to earnings Ratio 21.93 | 1Y Target Price 56.81 | ||
Volume (30-day avg) 20 | Beta 1.13 | 52 Weeks Range 45.34 - 62.49 | Updated Date 10/17/2025 |
52 Weeks Range 45.34 - 62.49 | Updated Date 10/17/2025 | ||
Dividends yield (FY) 0.66% | Basic EPS (TTM) 2.22 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 12.51% | Operating Margin (TTM) 17.33% |
Management Effectiveness
Return on Assets (TTM) 3.85% | Return on Equity (TTM) 7.36% |
Valuation
Trailing PE 21.93 | Forward PE 18.35 | Enterprise Value 19821883254 | Price to Sales(TTM) 2.68 |
Enterprise Value 19821883254 | Price to Sales(TTM) 2.68 | ||
Enterprise Value to Revenue 3.22 | Enterprise Value to EBITDA 12.56 | Shares Outstanding 338336345 | Shares Floating 319595895 |
Shares Outstanding 338336345 | Shares Floating 319595895 | ||
Percent Insiders 0.33 | Percent Institutions 100.88 |
Upturn AI SWOT
Fortive Corp
Company Overview
History and Background
Fortive Corp (FTV) was established in 2016 as a spin-off from Danaher Corporation. It retained a focus on industrial technologies, building on Danaher's expertise in instrumentation and industrial solutions. Since its inception, Fortive has grown through acquisitions and organic development, aiming to build a portfolio of leading brands.
Core Business Areas
- Intelligent Operating Solutions: This segment provides hardware, software, and services to optimize customers' workflows. It includes brands like Fluke and Tektronix. Solutions are used in various industrial, electronics, and healthcare markets.
- Precision Technologies: This segment offers sensing technologies, transportation technologies, and automation and specialty products. Core products include sensors, encoders, and controls systems for industrial applications.
- Advanced Healthcare Solutions: This segment provides infection prevention and sterile processing workflow solutions to healthcare providers.
Leadership and Structure
Fortive is led by a CEO and has a structured organizational framework. Its board of directors oversees governance. The company is organized into operating segments, each headed by a president responsible for segment performance.
Top Products and Market Share
Key Offerings
- Fluke Test and Measurement Tools: Fluke is a leading brand of electronic test and measurement tools for industrial, scientific, and educational applications. Competitors: Keysight Technologies (KEYS), Rohde & Schwarz, and Teledyne Technologies (TDY). Market share varies by product category but Fluke holds a significant portion of the test and measurement tool market. Fluke revenue is estimated around $2B annually.
- Tektronix Oscilloscopes: Tektronix is a major provider of oscilloscopes and other test and measurement equipment. Competitors: Keysight Technologies (KEYS), Rohde & Schwarz, and Yokogawa Electric Corporation. Tektronix holds a significant portion of the oscilloscope market. Tektronix revenue is estimated around $1.2B annually.
- ASP Infection Prevention: ASP (Advanced Sterilization Products) develops products and solutions for infection prevention, primarily in healthcare settings. Competitors include STERIS (STE) and Getinge. ASP holds a strong position in the global infection prevention market.
Market Dynamics
Industry Overview
The industry Fortive operates in encompasses industrial technologies, precision instrumentation, and healthcare solutions. This sector is characterized by continuous innovation, regulatory compliance, and the need for advanced technological capabilities. Growth is driven by increasing demand for automation, digitization, and improved healthcare outcomes.
Positioning
Fortive is positioned as a provider of essential technologies for industrial and healthcare applications. Its competitive advantages include a diverse product portfolio, strong brands, and a focus on innovation and customer solutions.
Total Addressable Market (TAM)
The estimated TAM for Fortive's segments is over $100 billion. Fortive is targeting specific niches within these markets, and is well-positioned to address the increasing market demand for smart equipment and automated services.
Upturn SWOT Analysis
Strengths
- Strong brand reputation
- Diverse product portfolio
- Experienced management team
- Focus on innovation
- Proven track record of acquisitions
Weaknesses
- Exposure to cyclical industries
- Dependence on key suppliers
- Integration challenges from acquisitions
- Currency exchange rate fluctuations
Opportunities
- Expansion into emerging markets
- Development of new products and services
- Strategic acquisitions
- Growing demand for automation and digitization
- Increasing healthcare spending
Threats
- Economic downturns
- Intense competition
- Rapid technological changes
- Regulatory changes
- Disruptive technologies
Competitors and Market Share
Key Competitors
- KEYS
- STE
- ROHDE&SCHWARZ
- TDY
Competitive Landscape
Fortive competes effectively through its diverse product portfolio and leading brands. However, companies like Keysight and STERIS have specialized strengths in their respective markets, posing competitive challenges. Fortive's ability to integrate acquisitions and innovate are key to maintaining its competitive edge.
Major Acquisitions
Provation
- Year: 2021
- Acquisition Price (USD millions): 1430
- Strategic Rationale: Expansion of healthcare solutions portfolio; entry into the growing market for clinical productivity software. Acquired from Wolters Kluwer.
Sensei
- Year: 2023
- Acquisition Price (USD millions): 780
- Strategic Rationale: Added software capabilities to the industrial automation sector, enhancing Fortive's digital offerings. This addition helped improve productivity, safety, and compliance.
Growth Trajectory and Initiatives
Historical Growth: Discuss Fortive Corp's growth trends over the past years.
Future Projections: Provide projections for Fortive Corp's future growth based on analyst estimates.
Recent Initiatives: Highlight recent strategic initiatives undertaken by Fortive Corp.
Summary
Fortive is a strong company with a diverse portfolio and a focus on innovation. Its strategic acquisitions have expanded its capabilities, especially in healthcare and industrial automation. The company faces challenges from economic cycles and competition but is well-positioned for future growth through digitalization and expansion into emerging markets. Fortive will need to keep integrating its acquisitions effectively.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company SEC Filings (10-K, 10-Q)
- Investor Presentations
- Analyst Reports
- Company Website
- Third-Party Market Research Reports
Disclaimers:
The information provided is for informational purposes only and should not be considered as financial advice. Market data and analyst estimates are subject to change. Investment decisions should be made based on individual research and consultation with a qualified financial advisor.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Fortive Corp
Exchange NYSE | Headquaters Everett, WA, United States | ||
IPO Launch date 2016-07-01 | President, CEO & Director Mr. Olumide Soroye J.D. | ||
Sector Technology | Industry Scientific & Technical Instruments | Full time employees 18000 | Website https://www.fortive.com |
Full time employees 18000 | Website https://www.fortive.com | ||
Fortive Corporation designs, develops, manufactures, and markets products, software, and services in the United States, China, and internationally. It operates through Intelligent Operating Solutions and Advanced Healthcare Solutions segments. The Intelligent Operating Solutions segment provides advanced instrumentation, software, and services, including electrical test and measurement, facility and asset lifecycle software applications, and connected worker safety and compliance solutions for manufacturing, process industries, healthcare, utilities and power, communications and electronics, and other industries. This segment markets its products and services under the ACCRUENT, FLUKE, GORDIAN, INDUSTRIAL SCIENTIFIC, INTELEX, PRUFTECHNIK, and SERVICECHANNEL brand names. The Advanced Healthcare Solutions segment provides critical workflow solutions comprising instrument sterilization, instrument tracking, design and manufacture of cell therapy equipment, biomedical test tools, radiation detection and safety monitoring, and end-to-end clinical productivity software and solutions under the ASP, CENSIS, CENSITRAC, EVOTECH, FLUKE BIOMEDICAL, INVETECH, LANDAUER, PROVATION, RAYSAFE, and STERRAD brand names. Fortive Corporation was incorporated in 2015 and is headquartered in Everett, Washington.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.